EMV Capital

Leading the next wave of Venture Capital investment

With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future, EMV Capital invests in, strengthens, and manages early stage companies with attractive Intellectual Property.

EMV Capital’s approach is characterised by: its proactive management style, aiming to advance companies to critical value inflection points; and capital-efficient investment model, utilising balance sheet and engaging in syndicate investments.

0

Portfolio locations
UK, Belgium, USA, Israel

£ 0 m

Total fair value of assets under management

0 +

Companies in
our managed portfolio

* As reported 13 June 2024

Capital efficient investment strategy

We use a combination of funding sources to gain (and increase) direct and indirect stakes in our portfolio companies, including syndicated investments, selective balance sheet investments to gain deeper stakes, as well as deploying funds from our Funds practice. This provides us with capital gain opportunities when we exit portfolio companies through direct disposals and carried interest from exit realisations for our investor base. Our platform’s flexibility allows us to support portfolio companies from their early stages through to successful exit.

Proactive portfolio management

We believe proactive management is key to obtaining superior returns and protecting the value of our holdings. Our approach involves taking Board positions, working closely with management and maintaining strong relationships with co-investors to coordinate strategies and objectives. We are an active, engaged investor deploying our expertise.

Value creation services

We concentrate on a select cohort of companies at a time, driving growth and investment realisations through fundraising support and value creation services. Our in-house operational team, venture partners, and panel of expert service providers offer support across functions including investment readiness, exit readiness, IP strategy, corporate collaborations, financial functions, and senior executive placements.

Operational income sources

Our financial realisations and income model is to finance the operations through a combination of operational fee income and modest divestments.

Capital realisation channels

We target the realisation of outsized investment returns through strategic partial or full exits from our directly owned positions (direct cash) and carried interest from Fund management exits. These exits are realised through M&A, IPOs, or sales to PE and other financial investors. This approach maximises value for our stakeholders through a variety of well-planned exit strategies.

Nanotechnology Medicine Technology July

We invest in technologies that will define our future

We invest in select companies with both high growth and impact potential and roll up our sleeves to support their growth over an extended period and secure sustainable returns for our investors.

Martlet Capital
ProAxsis
Glycotest
PDS Biotechnology
Q-Bot
Vortex Biosciences
EpiBone
Dname-iT
SageTech Medical
Ventive
Sofant Technologies
Wanda Health
PointGrab
DeepTech Recycling
FOx Biosystems
Cytovale
Cetromed
Oncocidia
G-Tech Medical
Longevity Biotech
QuantalX Neuroscience
Nanotech Industrial Solutions